Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 8(42), p. 872-875, 2024

DOI: 10.1200/jco.23.01196

Links

Tools

Export citation

Search in Google Scholar

Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Trial-level surrogacy is critical before early response endpoints are used to approve new therapies.